User menu

Impact of growth hormone (GH) treatment on circulating Nt-proBNP concentrations and on cardiac function in adult GH-deficient patients

Bibliographic reference Gruson, Damien ; Alexopoulou, Orsalia ; Cumps, Jean ; Pasquet, Agnes ; Ketelslegers, Jean-Marie ; et. al. Impact of growth hormone (GH) treatment on circulating Nt-proBNP concentrations and on cardiac function in adult GH-deficient patients. In: Scandinavian journal of clinical and laboratory investigation, Vol. 72, no. 5, p. 387-394 (2012)
Permanent URL http://hdl.handle.net/2078.1/123817
  1. Colao Annamaria, Marzullo Paolo, Di Somma Carolina, Lombardi Gaetano, Growth hormone and the heart, 10.1046/j.1365-2265.2001.01218.x
  2. Rosén T., Bengtsson B.-Å., Premature mortality due to cardiovascular disease in hypopituitarism, 10.1016/0140-6736(90)91812-o
  3. Bulow Birgitta, Hagmar Lars, Mikoczy Zoli, Nordstrom Carl-Henrik, Erfurth Eva Marie, Increased cerebrovascular mortality in patients with hypopituitarism, 10.1046/j.1365-2265.1997.d01-1749.x
  4. Colao A, J Clin Endocrinol Metab, 86, 1874 (2001)
  5. ter Maaten JC, J Clin Endocrinol Metab, 84, 2373 (1999)
  6. Maison P, Circulation, 108, 2648 (2003)
  7. Le Corvoisier Philippe, Hittinger Luc, Chanson Philippe, Montagne Olivier, Macquin-Mavier Isabelle, Maison Patrick, Cardiac Effects of Growth Hormone Treatment in Chronic Heart Failure: A Meta-Analysis, 10.1210/jc.2006-1313
  8. Cittadini Antonio, Saldamarco Lavinia, Marra Alberto Maria, Arcopinto Michele, Carlomagno Guido, Imbriaco Massimo, Del Forno Domenico, Vigorito Carlo, Merola Bartolomeo, Oliviero Ugo, Fazio Serafino, Saccà Luigi, Growth Hormone Deficiency in Patients with Chronic Heart Failure and Beneficial Effects of Its Correction, 10.1210/jc.2009-0533
  9. Cenci Maria Claudia Peixoto, Soares Débora Vieira, Spina Luciana Diniz Carneiro, de Lima Oliveira Brasil Rosane Resende, Lobo Priscila Marise, Mansur Vera Aleta, Gold Jaime, Michmacher Eduardo, Vaisman Mario, Conceição Flávia Lúcia, Effects of 5 years of growth hormone (GH) replacement therapy on cardiac parameters and physical performance in adults with GH deficiency, 10.1007/s11102-009-0182-2
  10. Palmeiro CR, Cardiol Rev. Forthcoming (2012)
  11. Epstein Franklin H., Levin Ellis R., Gardner David G., Samson Willis K., Natriuretic Peptides, 10.1056/nejm199807303390507
  12. Pfister R., Schneider C.A., Natriuretic peptides BNP and NT-pro-BNP: established laboratory markers in clinical practice or just perspectives?, 10.1016/j.cccn.2004.06.018
  13. Troughton Richard W., Richards A. Mark, B-Type Natriuretic Peptides and Echocardiographic Measures of Cardiac Structure and Function, 10.1016/j.jcmg.2008.12.006
  14. Berger R., B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure, 10.1161/01.cir.0000016642.15031.34
  15. Omland T., N-Terminal Pro-B-Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary Syndromes, 10.1161/01.cir.0000041661.63285.ae
  16. Kragelund Charlotte, Grønning Bjørn, Køber Lars, Hildebrandt Per, Steffensen Rolf, N-Terminal Pro–B-Type Natriuretic Peptide and Long-Term Mortality in Stable Coronary Heart Disease, 10.1056/nejmoa042330
  17. Omland Torbjørn, Sabatine Marc S., Jablonski Kathleen A., Rice Madeline Murguia, Hsia Judith, Wergeland Ragnhild, Landaas Sverre, Rouleau Jean L., Domanski Michael J., Hall Christian, Pfeffer Marc A., Braunwald Eugene, Prognostic Value of B-Type Natriuretic Peptides in Patients With Stable Coronary Artery Disease, 10.1016/j.jacc.2007.03.038
  18. Di Angelantonio E., Chowdhury R., Sarwar N., Ray K. K., Gobin R., Saleheen D., Thompson A., Gudnason V., Sattar N., Danesh J., B-Type Natriuretic Peptides and Cardiovascular Risk: Systematic Review and Meta-Analysis of 40 Prospective Studies, 10.1161/circulationaha.109.884866
  19. Wang Thomas J., Larson Martin G., Levy Daniel, Benjamin Emelia J., Leip Eric P., Omland Torbjorn, Wolf Philip A., Vasan Ramachandran S., Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death, 10.1056/nejmoa031994
  20. Rutten J. H.W., Mattace-Raso F. U.S., Steyerberg E. W., Lindemans J., Hofman A., Wieberdink R. G., Breteler M. M.B., Witteman J. C.M., van den Meiracker A. H., Amino-Terminal Pro-B-Type Natriuretic Peptide Improves Cardiovascular and Cerebrovascular Risk Prediction in the Population: The Rotterdam Study, 10.1161/hypertensionaha.109.143313
  21. Patton K. K., Ellinor P. T., Heckbert S. R., Christenson R. H., DeFilippi C., Gottdiener J. S., Kronmal R. A., N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation: The Cardiovascular Health Study, 10.1161/circulationaha.109.873265
  22. Ekman Bertil, Ohman Peter K., Arnqvist Hans J., Lindstrom Torbjorn, Nystrom Fredrik H., Individualized growth hormone substitution with normalized IGF-I levels does not stimulate the renin-angiotensin-aldosterone system, 10.1046/j.1365-2265.2002.01617.x
  23. Andreassen Mikkel, Faber Jens, Vestergaard Henrik, Kistorp Caroline, Kristensen Lars Østergaard, N-terminal pro-B-type natriuretic peptide in patients with growth hormone disturbances, 10.1111/j.1365-2265.2007.02782.x
  24. Johannsson Gudmundur, Sverrisdóttir Yrsa Bergmann, Ellegård Lars, Lundberg Per-Arne, Herlitz Hans, GH Increases Extracellular Volume by Stimulating Sodium Reabsorption in the Distal Nephron and Preventing Pressure Natriuresis, 10.1210/jcem.87.4.8394
  25. Wallaschofski H., Saller B., Spilcke-Liss E., Lerch M., Lohmann T., Eigenthaler M., Effects of Growth Hormone Treatment on B-type Natriuretic Peptide as a Marker of Heart Failure in Adults with Growth Hormone Deficiency, 10.1055/s-2006-954588
  26. Lazúrová I., Pura M., Wagnerová H., Tajtáková M., Sedláková M., Tomáš L’., Payer J., Hrúziková P., Vaňuga P., Podoba J., Trejbalová L‘., Popovic V., Koltowska-Häggström M., Effect of Growth Hormone Replacement Therapy on Plasma Brain Natriuretic Peptide Concentration, Cardiac Morphology and Function in Adults with Growth Hormone Deficiency, 10.1055/s-0029-1220688
  27. Andreassen Mikkel, Faber Jens, Kjær Andreas, Petersen Claus Leth, Kristensen Lars Østergaard, Cardiac function in growth hormone deficient patients before and after 1 year with replacement therapy: a magnetic resonance imaging study, 10.1007/s11102-010-0250-7
  28. Lang Roberto M., Bierig Michelle, Devereux Richard B., Flachskampf Frank A., Foster Elyse, Pellikka Patricia A., Picard Michael H., Roman Mary J., Seward James, Shanewise Jack S., Solomon Scott D., Spencer Kirk T., St John Sutton Martin, Stewart William J., Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology, 10.1016/j.echo.2005.10.005
  29. Januzzi James L., Camargo Carlos A., Anwaruddin Saif, Baggish Aaron L., Chen Annabel A., Krauser Daniel G., Tung Roderick, Cameron Renee, Nagurney J. Tobias, Chae Claudia U., Lloyd-Jones Donald M., Brown David F., Foran-Melanson Stacy, Sluss Patrick M., Lee-Lewandrowski Elizabeth, Lewandrowski Kent B., The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) study, 10.1016/j.amjcard.2004.12.032
  30. Van Beneden Ronald, Gurné Olivier, Selvais Philippe L., Ahn Sylvie A., Robert Annie R., Ketelslegers Jean-marie, Pouleur Hubert G., Rousseau Michel F., Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure: a 7-year follow-up study, 10.1016/j.cardfail.2004.04.001
  31. Brabant G., Wallaschofski H., Normal levels of serum IGF-I: determinants and validity of current reference ranges, 10.1007/s11102-007-0035-9
  32. Brabant Georg, von zur Mühlen Alexander, Wüster Christian, Ranke Michael B., Kratzsch Jürgen, Kiess Wieland, Ketelslegers Jean-Marie, Wilhelmsen Lars, Hulthén Lena, Saller Bernhard, Mattsson Anders, Wilde Jürgen, Schemer Rudolf, Kann Peter, Serum Insulin-Like Growth Factor I Reference Values for an Automated Chemiluminescence Immunoassay System: Results from a Multicenter Study, 10.1159/000071871
  33. Merola B, J Clin Endocrinol Metab, 77, 1658 (1993)
  34. Maison P., Cardiac Effects of Growth Hormone in Adults With Growth Hormone Deficiency: A Meta-Analysis, 10.1161/01.cir.0000100720.01867.1d
  35. Isgaard J., Tivesten Å., Friberg P., Bengtsson B.-Å., The Role of the GH/IGF-I Axis for Cardiac Function and Structure, 10.1055/s-2007-978698
  36. Colao A, J Clin Endocrinol Metab, 86, 1874 (2001)
  37. Climent Vicente E., Picó Antonio, Sogorb Francisco, Aznar Silvia, Lip Gregory Y.H., Marín Francisco, Growth Hormone Therapy and the Heart, 10.1016/j.amjcard.2005.10.054
  38. Jin Hongkui, Yang Renhui, Lu Hsienwie, Ogasawara Annie K, Li Wei, Ryan Anne, Peale Franklin, Paoni Nicholas F, Effects of early treatment with growth hormone on infarct size, survival, and cardiac gene expression after acute myocardial infarction, 10.1016/s1096-6374(02)00042-4
  39. Mulumba Mukandila, Céméus Catia, Dumont Louis, du Souich Patrick, Ong Huy, Marleau Sylvie, Recombinant bovine growth hormone-induced reduction of atrial natriuretic peptide is associated with improved left ventricular contractility and reverse remodeling in cardiomyopathic UM-X7.1 hamsters with congestive heart failure, 10.1016/j.ghir.2006.12.001
  40. Verhelst Johan, Abs Roger, Long-Term Growth Hormone Replacement Therapy in Hypopituitary Adults : , 10.2165/00003495-200262160-00006
  41. Ho Ken Y., Kelly John J., Role of Growth Hormone in Fluid Homeostasis, 10.1159/000182188
  42. Møller Jens, Nielsen Sten, Hansen Troels Krarup, Growth Hormone and Fluid Retention, 10.1159/000053173
  43. Alexopoulou O, Beguin C, De Nayer P, Maiter D, Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients, 10.1530/eje.0.1500001
  44. Hogenhuis Jochem, Voors Adriaan A., Jaarsma Tiny, Hillege Hans L., Boomsma Frans, van Veldhuisen Dirk J., Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP, 10.1016/j.ejheart.2004.03.014
  45. Loke Ian, Squire Iain B., Davies Joan E., Ng Leong L., Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate, 10.1016/s1388-9842(03)00108-9
  46. Emdin Michele, Passino Claudio, Ry Silvia Del, Prontera Concetta, Galetta Fabio, Clerico Aldo, Influence of Gender on Circulating Cardiac Natriuretic Hormones in Patients with Heart Failure, 10.1515/cclm.2003.104
  47. Mehra Mandeep R, Uber Patricia A, Park Myung H, Scott Robert L, Ventura Hector O, Harris Bobbett C, Frohlich Edward D, Obesity and suppressed B-type natriuretic peptide levels in heart failure, 10.1016/j.jacc.2003.10.066